Figure 6.
TGFβRI inhibition reduces serum-induced hCSC proliferation. (A) Application of TGFβRI inhibitor SB431542 reduces serum-mediated hCSC proliferation with an (B) IC50 of 0.5339 µM. (Ordinary one-way ANOVA, **** p < 0.0001; *** p < 0.001).
Official websites use .gov
A
.gov website belongs to an official
government organization in the United States.
Secure .gov websites use HTTPS
A lock (
) or https:// means you've safely
connected to the .gov website. Share sensitive
information only on official, secure websites.